Here are the top 5 news updates of June 3, 2021:
Mumbai is expected to get a supply of 87,000 doses of Covishield vaccine against COVID-19 on Friday and the inoculation drive would resume in the city the next day, Mayor Kishori Pednekar said on Thursday.
Due to the unavailability of enough vaccine doses, the COVID-19 vaccination drive in Mumbai was suspended on Thursday at centres run by the city civic body and the Maharashtra government, the Brihanmumbai Municipal Corporation (BMC) earlier said.
Of the total 342 active COVID-19 vaccination centres in Mumbai, 243 are managed by the BMC and 20 by the state government.
The Union Health Ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore COVID-19 vaccine doses for which it will be making an advance payment of Rs 1500 crore.
This is the second made-in-India vaccine after Bharat Biotech's COVAXIN. As per a health ministry statement on Thursday, these vaccine doses will be manufactured and stockpiled by Biological-E from August to December this year.
The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials. The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months.
The proposal of Biological-E was examined and recommended for approval after due diligence by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), the statement said.
The Gautam Gambhir Foundation has been found guilty of unauthorisedly stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi High Court was informed by the Delhi government's drug controller on Thursday.
The drug controller submitted that action will be taken without delay against the foundation, drug dealers as also in other such cases which would be brought to its notice.
MLA Praveen Kumar has also been found guilty for similar offences under the Drugs and Cosmetics Act, the court was informed.
The court asked the drug controller to file status reports on further progress in these cases within six weeks and listed the matter for hearing on July 29.
Tracking positive global cues, Indian equity market opened on a positive note while positive GDP data and declining COVID-19 cases also supported the sentiments. HDFC twins, Kotak bank, Titan and L&T were the top contributors to index gains. Index heavyweight Nifty Bank surged nearly 0.8 percent ahead of RBI’s monetary policy. All the sectoral indices ended in the green zone except Nifty Pharma while Nifty Realty was the top performer in today’s session.
Market participants will keep a close eye on US payroll data and RBI’s monetary policy which is scheduled tomorrow.
While the Nifty is moving towards 16,000, it has set a new record closing high. Titan, ONGC and L&T helped bring the Nifty to end at higher levels.